RCS - MicroVision, Inc. - MicroVision Appointment of Industry Veteran as CTO

MicrovisionAnnouncement

24/03/2025 14:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250324:nRSX8353Ba&default-theme=true

RNS Number : 8353B  MicroVision, Inc.  24 March 2025

MicroVision Announces Appointment of Industry Veteran as CTO

 

REDMOND, WA / ACCESS Newswire / March 24, 2025 / MicroVision, Inc.
(NASDAQ:MVIS), a technology pioneer delivering advanced perception solutions
in autonomy and mobility, today announced that industry veteran and technology
leader Glen W. DeVos will join the Company as Chief Technology Officer,
overseeing global engineering and product strategy at MicroVision. DeVos will
report to CEO Sumit Sharma.

"We are thrilled to have Glen join the MicroVision team," said Sumit Sharma,
MicroVision's Chief Executive Officer. "With over three decades of highly
relevant experience, Glen brings a deep understanding of the technological
solutions needed by leading industrial and automotive players as they develop
and refine their offerings and strategies. His insights, expertise, and
leadership will help MicroVision harness its innovative software and hardware
technologies to deliver the perception solutions needed to drive advancements
in autonomy and mobility."

"I am delighted to join MicroVision and look forward to working as part of the
leadership team to help accelerate the Company's go-to-market strategy," said
DeVos.

DeVos is a seasoned leader having dedicated his career to developing and
delivering technologies and solutions in the automotive and industrial
markets, specifically in autonomy and mobility. Since 1992, DeVos served in
various business leadership and technology roles at Aptiv, and its predecessor
Delphi Automotive, including as Aptiv's Chief Technology Officer and President
of the Advanced Safety and User Experience business unit. His extensive
experience leading large global teams and successfully launching high
complexity software and hardware platforms will be a tremendous asset in
driving MicroVision's growth.

About MicroVision

MicroVision drives global adoption of innovative perception solutions to make
mobility and autonomy safer. Fueled by engineering excellence in Redmond,
Washington and Hamburg, Germany, MicroVision develops and supplies an
integrated solution built on its perception software stack, incorporating
application software and processing data from differentiated sensor systems.
MicroVision's proprietary technology solutions deliver enhanced safety for a
variety of industrial applications, including robotics, automated warehouse,
and agriculture, and the automotive industry accelerating advanced
driver-assistance systems (ADAS) and autonomous driving, as well as for
military applications. With deep roots in MEMS-based laser beam scanning
technology that integrates MEMS, lasers, optics, hardware, algorithms and
machine learning software, MicroVision has the expertise to deliver safe
mobility at the speed of life.

For more information, visit the Company's website at www.microvision.com
(https://pr.report/6peh) , on Facebook at www.facebook.com/microvisioninc
(https://pr.report/6pes) , and LinkedIn at
https://www.linkedin.com/company/microvision/ (https://pr.report/6pei) .

MicroVision, MAVIN, MOVIA, and MOSAIK are trademarks of MicroVision, Inc. in
the United States and other countries. All other trademarks are the properties
of their respective owners.

Forward-Looking Statements

Certain statements contained in this release, including execution of strategy
and growth prospects are forward-looking statements that involve a number of
risks and uncertainties that could cause actual results to differ materially
from those in the forward-looking statements. Factors that could cause actual
results to differ materially from those projected in such forward-looking
statements include the risk its ability to operate with limited cash or to
raise additional capital when needed; market acceptance of its technologies
and products or for products incorporating its technologies; the failure of
its commercial partners to perform as expected under its agreements; its
financial and technical resources relative to those of its competitors; its
ability to keep up with rapid technological change; government regulation of
its technologies; its ability to enforce its intellectual property rights and
protect its proprietary technologies; the ability to obtain customers and
develop partnership opportunities; the timing of commercial product launches
and delays in product development; the ability to achieve key technical
milestones in key products; dependence on third parties to develop,
manufacture, sell and market its products; potential product liability claims;
its ability to maintain its listing on The Nasdaq Stock Market, and other risk
factors identified from time to time in the Company's SEC reports, including
the Company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and
other reports filed with the SEC. These factors are not intended to represent
a complete list of the general or specific factors that may affect the
Company. It should be recognized that other factors, including general
economic factors and business strategies, may be significant, now or in the
future, and the factors set forth in this release may affect the Company to a
greater extent than indicated. Except as expressly required by federal
securities laws, the Company undertakes no obligation to publicly update or
revise any forward-looking statements, whether as a result of new information,
future events, changes in circumstances or any other reason.

Investor Relations Contact

Jeff Christensen

Darrow Associates Investor Relations

MVIS@darrowir.com

Media Contact

Marketing@MicroVision.com

SOURCE: MicroVision, Inc

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAKZGZFMDNGKZG